3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fatigue
6
Brain Neoplasms
3
Sleep Wake Disorders
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Pain
1
Mental Disorders
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Depression
1
Central Nervous System Neoplasms
1
Caregiver Burden
1
Breast Neoplasms
1
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
Methylphenidate
×
Clear all
No trials found.